Literature DB >> 8813578

Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats.

A Honkanen1, L Vilamo, K Wegelius, M Sarviharju, P Hyytiä, E R Korpi.   

Abstract

To assess the roles of opioid receptor subtypes in voluntary alcohol drinking, alcohol-preferring AA (Alko, Alcohol) rats, non-deprived of food or water, were used in a paradigm where access to 10% alcohol solution was limited to 1-4-h sessions on every 2nd working day. The delta-opioid receptor antagonist naltrindole (1-5 mg/kg i.p. 15 min before the session) had no effect on alcohol drinking, while it attenuated the delta-opioid receptor agonist [D-Pen2, D-Pen5]enkephalin-induced locomotor stimulation. The mu1-opioid receptor antagonist naloxonazine (1-15 mg/kg i.p. 20 h before the session), at the largest dose, decreased alcohol drinking. It also decreased food intake. When naltrindole (1 mg/kg) and naloxonazine (15 mg/kg) were given prior to 3 consecutive sessions, the former had no effects at any session. Naloxonazine decreased alcohol consumption only in the 1st session, although the reduction of daily water intake became stronger during repeated administration. 4 days after the last drug administration, naloxonazine-treated animals consumed alcohol nearly twice as much as in the control session before any drug treatment. These data suggest that delta-opioid receptors are not involved in the regulation of alcohol drinking in AA rats. mu1-Opioid receptors may be involved in alcohol drinking, although the data suggest that even their prolonged blockade alone is insufficient to induce a sustained decrease in alcohol drinking.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813578     DOI: 10.1016/0014-2999(96)00118-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

Review 1.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 2.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

Review 3.  The opioidergic-alcohol link : implications for treatment.

Authors:  Vania Modesto-Lowe; Eleanor M Fritz
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism.

Authors:  C Gianoulakis
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

5.  Long-term behavioral effects of repetitive pain in neonatal rat pups.

Authors:  K J Anand; V Coskun; K V Thrivikraman; C B Nemeroff; P M Plotsky
Journal:  Physiol Behav       Date:  1999-06

6.  Activity and expression of enkephalinase and aminopeptidase N in regions of the mesocorticolimbic system are selectively modified by acute ethanol administration.

Authors:  Marcela Morales-Mulia; Patricia de Gortari; María-Isabel Amaya; Milagros Méndez
Journal:  J Mol Neurosci       Date:  2011-08-26       Impact factor: 3.444

7.  Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.

Authors:  Angela Henderson-Redmond; Cristine Czachowski
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

Review 8.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

9.  The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake.

Authors:  Richard M van Rijn; Jennifer L Whistler
Journal:  Biol Psychiatry       Date:  2009-07-03       Impact factor: 13.382

10.  Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens.

Authors:  R A Gonzales; F Weiss
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.